Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990883 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)
A NA study of Dermatological Non-Disease, sponsored by Croma-Pharma.
- Completed
- Registry status
- NA
- Development phase
- 295
- Enrollment target
- 11
- Study locations
NCT03990883 is a NA study of Dermatological Non-Disease that has completed, run by Croma-Pharma. The registered enrollment target is 295 participants. The trial reports 11 study locations across 9 states.
The verdict
NCT03990883, a NA study of Dermatological Non-Disease, has completed, sponsored by Croma-Pharma.
- COMPLETED
- Registry status
- NA
- Development phase
- 295 participants
- Enrollment target
- 11
- Study locations
Study Summary
Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds
Conditions Studied
Interventions
- DEVICE Princess Filler Lidocaine
Study Locations (11)
California
- John Joseph - Beverly Hills
- Sabrina Fabi - San Diego
- Ava Shamban - Santa Monica
Alabama
- Gary Monheit - Birmingham
Colorado
- Joel Cohen - Greenwood Village
Florida
- Jeremy Green - Coral Gables
Maryland
- Robert Weiss - Hunt Valley
New Jersey
- Jeanine Downie - Montclair
New York
- The Center for Dermatology Cosmetic and Laser Surgery - New York
Pennsylvania
- Susan Taylor - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2019-06-04 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03990883
The ClinicalTrials.gov registry entry for NCT03990883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Croma-Pharma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatological Non-Disease appearing as the primary indexed condition, and to 1 intervention - of which Princess Filler Lidocaine is the first listed.
NCT03990883 reports 11 study locations spanning 9 distinct geographic areas - top geographies include California, Alabama, Colorado.
Frequently Asked Questions
What is clinical trial NCT03990883 about?
NCT03990883 is a clinical study titled "Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)". Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds
What is the current status of trial NCT03990883?
This trial is currently completed. It is a NA study. The enrollment target is 295 participants. The study started on 2019-06-04. Estimated completion is 2022-02-15.
What conditions does trial NCT03990883 study?
This clinical trial studies the following conditions: Dermatological Non-Disease.
What interventions are being tested in trial NCT03990883?
The interventions under investigation include: Princess Filler Lidocaine (DEVICE).
Who is sponsoring clinical trial NCT03990883?
This trial is sponsored by Croma-Pharma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990883 being conducted?
This trial has 11 study locations across Alabama, California, Colorado, Florida, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatological Non-Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.